Patents by Inventor Astrid Markus

Astrid Markus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120329835
    Abstract: Compounds of the formula (1) are disclosed and are suitable for the treatment of seborrheic dermatitis.
    Type: Application
    Filed: July 23, 2012
    Publication date: December 27, 2012
    Applicant: MEDICIS PHARMACEUTICAL CORPORATION
    Inventors: Manfred Bohn, Karl Theodor Kraemer, Astrid Markus
  • Patent number: 8227490
    Abstract: Compounds of the formula (I) are disclosed and are suitable for the treatment of seborrheic dermatitis.
    Type: Grant
    Filed: July 7, 2011
    Date of Patent: July 24, 2012
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Manfred Bohn, Karl Theodor Kraemer, Astrid Markus
  • Publication number: 20110269801
    Abstract: Compounds of the formula (I) are disclosed and are suitable for the treatment of seborrheic dermatitis.
    Type: Application
    Filed: July 7, 2011
    Publication date: November 3, 2011
    Inventors: Manfred Bohn, Karl Theodor Kraemer, Astrid Markus
  • Patent number: 7981909
    Abstract: Compounds of the formula (I) are disclosed and are suitable for the treatment of seborrheic dermatitis.
    Type: Grant
    Filed: January 31, 2011
    Date of Patent: July 19, 2011
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Manfred Bohn, Karl Theodor Kraemer, Astrid Markus
  • Publication number: 20110112153
    Abstract: Compounds of the formula (I) are disclosed and are suitable for the treatment of seborrheic dermatitis.
    Type: Application
    Filed: January 31, 2011
    Publication date: May 12, 2011
    Inventors: Manfred Bohn, Karl Theodor Kraemer, Astrid Markus
  • Publication number: 20110112150
    Abstract: Compounds of the formula (I) are disclosed and are suitable for the treatment of seborrheic dermatitis.
    Type: Application
    Filed: September 21, 2009
    Publication date: May 12, 2011
    Inventors: Manfred Bohn, Karl Kraemer, Astrid Markus
  • Publication number: 20100076031
    Abstract: Compounds of the formula (I) are disclosed and are suitable for the treatment of seborrheic dermatitis.
    Type: Application
    Filed: September 21, 2009
    Publication date: March 25, 2010
    Inventors: Manfred Bohn, Karl Theodor Kraemer, Astrid Markus
  • Patent number: 7285619
    Abstract: Compounds of the formula wherein the substituents are as defined in the application useful as antifungal agents.
    Type: Grant
    Filed: June 23, 2005
    Date of Patent: October 23, 2007
    Assignee: Aventis Pharma S.A.
    Inventors: Olivier Courtin, Patrick Fauveau, Astrid Markus, Dominique Melon Manguer, Jean-Marc Michel, Laurent Schio
  • Patent number: 7160983
    Abstract: Compound of the formula wherein R2 is —CH2—CH2—NH2, R3 is —CH3, R4 is —OH, R is Z is methyl and salts thereof which are useful as antifungal agents.
    Type: Grant
    Filed: September 19, 2003
    Date of Patent: January 9, 2007
    Assignee: Aventis Pharma S.A.
    Inventors: Olivier Courtin, Patrick Fauveau, Astrid Markus, Dominique Melon Manguer, Jean-Marc Michel, Laurent Schio
  • Patent number: 7148254
    Abstract: The present invention relates to 2-phenylbenzofurans of formula (I) which are formed, during fermentation, by the microorganism Aspergillus flavipes ST003878 (DSM 15290), to a process for preparing them and to their use as pharmaceuticals for the treatment and/or prophylaxis of bacterial infectious diseases or mycoses.
    Type: Grant
    Filed: October 25, 2004
    Date of Patent: December 12, 2006
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Laszlo Vertesy, Michael Kurz, Astrid Markus-Erb, Luigi Toti
  • Patent number: 7112608
    Abstract: The present invention relates to novel hydroxyphenylundecane derivatives of the formula (I), a method for the preparation of said compounds by cultivation of the fungus Cryphonectria parasitica, DSM 14453, and their use as pharmaceuticals, i.e. for the treatment of Alzheimer's Disease, Parkinson's Disease, Huntington's Diseases, stroke, psychosis and/or depressions.
    Type: Grant
    Filed: October 1, 2003
    Date of Patent: September 26, 2006
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Cordula Hopmann, Martin Knauf, Mark Brönstrup, Astrid Markus-Erb, Luigi Toti
  • Publication number: 20060121118
    Abstract: A pharmaceutical preparation comprising a hydrophilic gel-forming agent, water and a compound of the formula I is suitable for the treatment and prophylaxis of dermatomycoses.
    Type: Application
    Filed: January 31, 2006
    Publication date: June 8, 2006
    Inventors: Manfred Bohn, Karl Kraemer, Astrid Markus
  • Patent number: 7026337
    Abstract: A pharmaceutical preparation comprising a hydrophilic gel-forming agent, water and a compound of the formula I is suitable for the treatment and prophylaxis of dermatomycoses.
    Type: Grant
    Filed: October 23, 2003
    Date of Patent: April 11, 2006
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Manfred Bohn, Karl Theodor Kraemer, Astrid Markus
  • Patent number: 7018656
    Abstract: A pharmaceutical preparation comprising a hydrophilic gel-forming agent, water and a compound of the formula I is suitable for the treatment and prophylaxis of dermatomycoses.
    Type: Grant
    Filed: September 16, 1997
    Date of Patent: March 28, 2006
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Manfred Bohn, Karl Theodor Kraemer, Astrid Markus
  • Publication number: 20050267019
    Abstract: Compounds of the formula wherein the substituents are as defined in the application useful as antifungal agents.
    Type: Application
    Filed: June 23, 2005
    Publication date: December 1, 2005
    Inventors: Oliver Courtin, Patrick Fauveau, Astrid Markus, Dominique Melon Manguer, Jean-Marc Michel, Laurent Schio
  • Patent number: 6962943
    Abstract: The present invention relates to compounds of the formula (I) which are formed by the microorganism ST 003236 (DSM 14476) during fermentation, to a process for preparing and derivatizing them, to a pharmaceutical which comprises a compound of the formula (I) and to the use thereof for producing a pharmaceutical.
    Type: Grant
    Filed: November 8, 2002
    Date of Patent: November 8, 2005
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Matthias Schiell, Martin Knauf, Luigi Toti, Astrid Markus-Erb
  • Publication number: 20050137254
    Abstract: The present invention relates to 2-phenylbenzofurans of formula (I) which are formed, during fermentation, by the microorganism Aspergillus flavipes ST003878 (DSM 15290), to a process for preparing them and to their use as pharmaceuticals for the treatment and/or prophylaxis of bacterial infectious diseases or mycoses.
    Type: Application
    Filed: October 25, 2004
    Publication date: June 23, 2005
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Laszlo Vertesy, Michael Kurz, Astrid Markus-Erb, Luigi Toti
  • Publication number: 20040122092
    Abstract: The present invention relates to novel hydroxyphenylundecane derivatives of the formula (I), 1
    Type: Application
    Filed: October 1, 2003
    Publication date: June 24, 2004
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Cordula Hopmann, Martin Knauf, Mark Bronstrup, Astrid Markus-Erb, Luigi Toti
  • Publication number: 20040081677
    Abstract: A pharmaceutical preparation comprising a hydrophilic gel-forming agent, water and a compound of the formula I 1
    Type: Application
    Filed: October 23, 2003
    Publication date: April 29, 2004
    Applicant: Aventis Pharma Deutschland GmbH.
    Inventors: Manfred Bohn, Karl Theodor Kraemer, Astrid Markus
  • Publication number: 20040072737
    Abstract: Novel compounds of the formula 1
    Type: Application
    Filed: September 19, 2003
    Publication date: April 15, 2004
    Applicant: Aventis Pharma S.A.
    Inventors: Olivier Courtin, Patrick Fauveau, Astrid Markus, Dominique Melon Manguer, Jean-Marc Michel, Laurent Schio